EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 36-month data from its TRANSCEND clinical trial was presented by Dr. Peter A. Schneider at the 50th Annual VEITH Symposium in New York,…Read More
Surmodics Announces TRANSCEND Trial 36Month Data Presented at 50th Annual VEITH Symposium
